FCRL1 and diffuse large B-cell lymphoma: Second, FCRL1 mRNA expression emerged as a robust independent prognostic indicator, with high expression levels significantly correlating with reduced PFS and OS in Egyptian DLBCL patients receiving R-CHOP therapy.